🔎 Trials Near Me

Home › B-Cell Lymphoma › Ohio › Columbus

B-Cell Lymphoma clinical trials in Columbus, OH

7 studies for B-Cell Lymphoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

RecruitingPhase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Ohio Health Research Institute, Columbus
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06742996

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

RecruitingPhase 2
  • Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06052826

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
  • Research Site, Columbus
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

RecruitingPhase 1/2
  • Research Site, Columbus
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06564038

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Recruiting
  • Ohio State University Comprehensive Cancer Center, Columbus
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT07609030

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Nationwide Children's Hospital, Columbus
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

B-Cell Lymphoma trials in other cities

Other studies in Columbus

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.